Caribou Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +19.8% | +9.3% | +64.8% | +117.3% | +11.4% | -7.2% | |
| – | -18.8% | +244.2% | +239.7% | +17.4% | +21.5% | -24.1% | |
| – | – | +11,618.8% | +524.9% | – | – | – | |
| – | – | +16,322.0% | -114.5% | – | – | – | |
| – | +48.8% | +137.3% | +126.0% | +64.6% | -44.0% | -79.1% | |
| – | -76.6% | -2,872.2% | -47.1% | -26.9% | – | +18.0% | |
| – | – | – | – | – | – | – | |
| – | – | -29.6% | -100.0% | – | – | – | |
| – | +908.7% | +24,881.5% | -99.5% | +7,133.8% | -89.2% | -71.2% | |
| – | – | – | -181.1% | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.